HIV protease inhibitors head to market.
Stone
D
D
Cowen & Co., Boston, MA, USA.
D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors